发明授权
- 专利标题: Heterocyclic compounds as protein kinase inhibitors
- 专利标题(中): 杂环化合物作为蛋白激酶抑制剂
-
申请号: US14088093申请日: 2013-11-22
-
公开(公告)号: US08980911B2公开(公告)日: 2015-03-17
- 发明人: Ashwani Kumar Verma , Kumaragurubaran Nagaswamy , Lalima Sharma , Soma Ghosh , Balkrishna Ramchandra Kale , Aniruddha Mondal , Punit Kumar Srivastava , Sunanda Ghosh Dastidar , Rijwan Jaffer Momin , Pradip Balu Wagh , Sonali Nanasaheb Pansare , Pramod Raosaheb Markad , Yogesh Balasaheb Khairnar , Rie Miyauchi , Takeshi Murata , Masayuki Ishizaki , Masatoshi Nagamochi , Shin Iimura
- 申请人: Daiichi Sankyo Company, Limited
- 申请人地址: JP Chuo-ku
- 专利权人: Daiichi Sankyo Company, Limited
- 当前专利权人: Daiichi Sankyo Company, Limited
- 当前专利权人地址: JP Chuo-ku
- 代理机构: Christensen O'Connor Johnson Kindness PLLC
- 优先权: IN1510/DEL/2011 20110526
- 主分类号: C07D401/02
- IPC分类号: C07D401/02 ; C07D401/10 ; A61K31/437 ; A61K31/4353 ; C07D471/04
摘要:
The present invention provides a heterocyclic compound of formula (I), a pharmaceutically acceptable salt thereof, a prodrug thereof or a hydrate thereof, wherein A, A′ B, D, R1, R2 and R3 are as defined herein, a pharmaceutical composition comprising a compound of formula (I) as an active ingredient, methods of production, and methods of use thereof. Particularly, the present invention provides a compound of formula (I) useful for treating or preventing a disease, condition or disorder associated with protein kinases, preferably Janus Kinase family.
公开/授权文献
- US20140155398A1 HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS 公开/授权日:2014-06-05
信息查询